Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.
Hornik CP, Gonzalez D, van den Anker J, Atz AM, Yogev R, Poindexter BB, Ng KC, Delmore P, Harper BL, Melloni C, Lewandowski A, Gelber C, Cohen-Wolkowiez M, Lee JH; Pediatric Trial Network Steering Committee. Hornik CP, et al. Among authors: van den anker j. J Clin Pharmacol. 2018 Aug;58(8):1092-1104. doi: 10.1002/jcph.1116. Epub 2018 Apr 20. J Clin Pharmacol. 2018. PMID: 29677389 Free PMC article.
Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections.
Smith PB, Cohen-Wolkowiez M, Castro LM, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Bhatt-Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Brozanski BS, Sanchez P, van den Anker J, Blumer J, Kearns GL, Capparelli EV, Anand R, Benjamin DK Jr; Meropenem Study Team. Smith PB, et al. Among authors: van den anker j. Pediatr Infect Dis J. 2011 Oct;30(10):844-9. doi: 10.1097/INF.0b013e31822e8b0b. Pediatr Infect Dis J. 2011. PMID: 21829139 Free PMC article.
Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.
Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Rich W, Brozanski BS, van den Anker J, Blumer J, Laughon M, Watt KM, Kearns GL, Capparelli EV, Martz K, Berezny K, Benjamin DK Jr, Smith PB; Meropenem Study Team. Cohen-Wolkowiez M, et al. Among authors: van den anker j. Clin Infect Dis. 2012 Dec;55(11):1495-502. doi: 10.1093/cid/cis758. Epub 2012 Sep 5. Clin Infect Dis. 2012. PMID: 22955430 Free PMC article.
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants.
Cohen-Wolkowiez M, Sampson M, Bloom BT, Arrieta A, Wynn JL, Martz K, Harper B, Kearns GL, Capparelli EV, Siegel D, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act–Pediatric Trials Network. Cohen-Wolkowiez M, et al. Pediatr Infect Dis J. 2013 Sep;32(9):956-61. doi: 10.1097/INF.0b013e3182947cf8. Pediatr Infect Dis J. 2013. PMID: 23587979 Free PMC article. Clinical Trial.
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.
Hornik CP, Herring AH, Benjamin DK Jr, Capparelli EV, Kearns GL, van den Anker J, Cohen-Wolkowiez M, Clark RH, Smith PB; Best Pharmaceuticals for Children Act-Pediatric Trials Network. Hornik CP, et al. Among authors: van den anker j. Pediatr Infect Dis J. 2013 Jul;32(7):748-53. doi: 10.1097/INF.0b013e31828be70b. Pediatr Infect Dis J. 2013. PMID: 23838776 Free PMC article.
Population pharmacokinetics of intravenous acyclovir in preterm and term infants.
Sampson MR, Bloom BT, Lenfestey RW, Harper B, Kashuba AD, Anand R, Benjamin DK Jr, Capparelli E, Cohen-Wolkowiez M, Smith PB; Best Pharmaceuticals for Children Act–Pediatric Trials Network. Sampson MR, et al. Pediatr Infect Dis J. 2014 Jan;33(1):42-9. doi: 10.1097/01.inf.0000435509.75114.3d. Pediatr Infect Dis J. 2014. PMID: 24346595 Free PMC article. Clinical Trial.
Medication use in the neonatal intensive care unit.
Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act—Pediatric Trials Network. Hsieh EM, et al. Am J Perinatol. 2014 Oct;31(9):811-21. doi: 10.1055/s-0033-1361933. Epub 2013 Dec 17. Am J Perinatol. 2014. PMID: 24347262 Free PMC article.
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.
Tremoulet A, Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Salgado A, Ian-U Chong S, Melloni C, Gao J, Benjamin DK Jr, Capparelli EV, Cohen-Wolkowiez M; Administrative Core Committee of the Best Pharmaceuticals for Children Act-Pediatric Trials Network. Tremoulet A, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3013-20. doi: 10.1128/AAC.02374-13. Epub 2014 Mar 10. Antimicrob Agents Chemother. 2014. PMID: 24614374 Free PMC article. Clinical Trial.
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.
Gonzalez D, Melloni C, Yogev R, Poindexter BB, Mendley SR, Delmore P, Sullivan JE, Autmizguine J, Lewandowski A, Harper B, Watt KM, Lewis KC, Capparelli EV, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee. Gonzalez D, et al. Clin Pharmacol Ther. 2014 Oct;96(4):429-37. doi: 10.1038/clpt.2014.134. Epub 2014 Jun 20. Clin Pharmacol Ther. 2014. PMID: 24949994 Free PMC article. Clinical Trial.
Intestinal fatty-acid binding protein and metronidazole response in premature infants.
Sampson MR, Bloom BT, Arrieta A, Capparelli E, Benjamin DK Jr, Smith PB, Kearns GL, van den Anker J, Cohen-Wolkowiez M. Sampson MR, et al. Among authors: van den anker j. J Neonatal Perinatal Med. 2014 Jan 1;7(3):223-8. doi: 10.3233/NPM-1477013. J Neonatal Perinatal Med. 2014. PMID: 25318626 Free PMC article. Clinical Trial.
582 results